Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0001209191-21-053380

10% owner sold 105,894 shares at an average $29.29 ($3,101,344)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
UBS Oncology Impact Fund L.P. 10% owner 2021-08-23 Sale −53,359 $29.11 $1,553,280 7,858,018 D
UBS Oncology Impact Fund L.P. 10% owner 2021-08-24 Sale −50,822 $29.48 $1,498,233 7,807,196 D
UBS Oncology Impact Fund L.P. 10% owner 2021-08-25 Sale −1,713 $29.09 $49,831 7,805,483 D
Open-market sales · 105,894 sh · avg $29.29 · $3,101,344
Loading xslF345X03/doc4.xml…